IGMS
|IGM Biosciences Inc
NASDAQ
USD 1.17
-0.02|-1.68%
Current Price
USD 1.17
Change
USD -0.02 (-1.68%)
P/E Ratio
Dividend Yield
Market Cap
79.35M
Volume
126,639
Open
USD 1.17
Previous Close
USD 1.19
52-Week High
USD 22.50
52-Week Low
USD 0.92
About IGM Biosciences Inc
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
Sector:Healthcare
Industry:Biotechnology
CEO:Ms. Mary Beth Harler M.D.
Employees:54
Headquarters:Mountain View, USA
Website:igmbio.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions